Tornandizo, Conchita .
HRN: 04-47-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/01/2023
05/08/2023
IV
500mg
Q8H
AGE WITH MODERATE DEHYDRATION
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes